Delivery Order SPE2DB22D2211-SPE2DB23FPCT9
Award Date 9/7/23
Potential Completion Date 9/8/23
Potential Value $406
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $42,390 by the Defense Logistics Agency to provide 100 capsules of 25mg dextroamphetamine-amphetamine extended release for use by the Department of Defense. The single day contract has a period of performance from September 11-12, 2023 and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at $60,930 by the Defense Logistics Agency to provide 100 capsules of 20mg dextroamphetamine-amphetamine extended release for pharmaceutical use. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of 3 days from July 7-10, 2023. The firm fixed price contract was awarded under the DLA's indefinite-delivery/indefinite-quantity...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $12,810 by the Defense Logistics Agency to provide 100 capsules of 10mg dextroamphetamine-amphetamine extended release for use by the Department of Defense. The single day order is to be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 12, 2023. No additional details were provided regarding the solicitation or...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $12,810 by the Defense Logistics Agency to provide 100 capsules of 10mg dextroamphetamine-amphetamine extended release for use by the Department of Defense. The single day order is to be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 27, 2023. No additional details were provided regarding the solicitation or any...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at $243.72 by the Defense Logistics Agency to provide 100 capsules of 20mg dextroamphetamine-amphetamine extended release for performance from July 7-10, 2023. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania. The contract is a firm fixed price delivery order issued against the DLA's indefinite-delivery/indefinite-quantity...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $197,440 delivery order by the Defense Logistics Agency to supply 100 capsules of 10mg dextroamphetamine-amphetamine extended release. The order is to be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania under firm fixed pricing by August 11, 2023. The Defense Logistics Agency utilizes an indefinite-delivery/indefinite-quantity multiple award contract vehicle for...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $399.53 firm fixed price delivery order by the Defense Logistics Agency to supply 100 capsules of 15mg dextroamphetamine extended release. The single day contract has a period of performance from September 7-8, 2023, with all work to be conducted in Conshohocken, Pennsylvania. No major subcontractors or set aside designations were identified. This delivery order was issued against an existing...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $28,260 by the Defense Logistics Agency to provide 100 capsules of 25mg dextroamphetamine-amphetamine extended release capsules. The single day contract has a period of performance from September 11-12, 2023 and will be performed in Conshohocken, Pennsylvania. No additional details were provided regarding the solicitation or vehicle against which this...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $110,070 delivery order by the Defense Logistics Agency to supply 100 capsules of 20mg dextroamphetamine-amphetamine extended release. The order is to be fulfilled by September 14, 2023 from Amerisourcebergen's facility in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order is associated with any particular agency...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $81,000 firm fixed price delivery order by the Defense Logistics Agency to supply 100 capsules of 15mg dextroamphetamine-amphetamine extended release capsules. The single day delivery order performance period is September 5-6, 2023 with performance taking place in Conshohocken, Pennsylvania. No additional details were provided on the original solicitation or any overarching contract vehicles....
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB23FPCT9Delivery Order
Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $406,200 delivery order by the Defense Logistics Agency to provide 100 capsules of 20mg dextroamphetamine-amphetamine extended release medication. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two-day period concluding on September 8, 2023. The firm fixed price contract was issued under the DLA's indefinite-delivery/indefinite-quantity pharmaceuticals contract vehicle to supply the Agency's medical treatment facilities and contingency operations with prescribed medications. No subcontractors or set-aside designations were identified.
Generated 12/24/23, 9:37 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $406 | 9/7/23 |